Green Mountain Logic has announced that Advanced Biomedical Research (ABR) has selected LabPAS/CT to streamline the management of its Phase I clinical trials
ABR is a full-service CRO headquartered in Princeton, New Jersey and has a 72-bed research clinic in northern New Jersey where it performs a wide range of scientifically and technically sophisticated Phase I-II clinical studies.
According to Michael Willett, ABR's president and CEO, "We looked at a number of systems knowing we needed a solution that was adaptable, scalable, and proven".
"LabPAS/CT was the only one to meet these needs and provide a complete, end-to-end solution for Phase I clinical research".
"It assures compliance, tracks and schedules samples and manages workflow, while assuring a very high level of accuracy." LabPAS/CT is an EDC and workflow management solution already in use in a 500+bed US CRO conducting Phase I clinical trials.
Through the innovative use of barcode scanning of sample and subject it eliminates errors, increases productivity and facilitates compliance with FDA 21 Part 11.
John Rosenblum, CEO of Green Mountain Logic, noted: "The partnership with ABR's management team has been very important to us".
"Their clarity of vision and total commitment to conducting quality studies has helped us establish LabPAS/CT as the leading workflow and sample management solution for Phase I clinical trials."
